THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14481467

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(−)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KOWA COMPANY LTDNAKA-KU NAGOYA-SHI AICHI 460-8625
KYUSHU UNIVERSITY NATIONAL UNIVERSITY CORPORATIONNISHI-KU FUKUOKA-SHI FUKUOKA 819-0395

International Classification(s)

loading....
  • 2014 Application Filing Year
  • A61K Class
  • 14144 Applications Filed
  • 11600 Patents Issued To-Date
  • 82.02 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances2014201520162017201820192020202120222023202420250255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arita, Ryoichi Fukuoka-shi, JP 6 14
Ishibashi, Tatsuro Fukuoka-shi, JP 13 48
Mizuno, Ken Higashimurayama-shi, JP 26 80
Nakao, Shintaro Fukuoka-shi, JP 8 5
Tsuchiura, Akifumi Tokyo, JP 6 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 4 Citation Count
  • A61K Class
  • 21.20 % this patent is cited more than
  • 11 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges1767499999127813872291511752101 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +0250500750100012501500175020002250250027503000325035003750400042504500475050005250

Forward Cite Landscape

Load Citation